Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Trehalose’s untapped mechanisms in alzheimer’s: gut–brain–autophagy signalling beyond the usual targets
Daru Journal of Pharmaceutical Sciences
December 2026
Gunasekaran S.K.
Open Access
Untargeted Metabolomic Analysis of Honey of Four Botanical Origins Using Conventional and Sugar-Suppressed 1D and 2D NMR Spectroscopy
ACS Food Science and Technology
17 July 2026
Singh U.
Nrf2–Keap1 Pathway and NLRP3 Inflammasome in Parkinson’s Disease: Mechanistic Crosstalk and Therapeutic Implications
Molecular Neurobiology
January 2026
Jain R.
Open Access
Direct hybridization and bioinformatics analysis of circulating microRNAs in patients with Alzheimer's disease under intravenous trehalose treatment
Brain Research
15 June 2025
Radbakhsh S.
Molecular mechanisms of neuroprotection: The interplay of Klotho, SIRT-1, Nrf2, and HO-1 in neurological health
Behavioural Brain Research
8 May 2025
Rana R.
Advances in Disease Modifying Therapies for Parkinson’s Disease
Trends in CNS Drug Discovery
1 January 2025
Hassanzadeh K.
Trehalose Attenuates In Vitro Neurotoxicity of 6-Hydroxydopamine by Reducing Oxidative Stress and Activation of MAPK/AMPK Signaling Pathways
International Journal of Molecular Sciences
October 2024
Stevanovic D.
Open Access
The Possible Neuroprotective Role of Selenium in Arsenic-Induced Midbrain Substantia Nigra Neurotoxicity in Guinea Pig Model: Biochemical and Histological Study
Egyptian Journal of Histology
June 2024
Rahman M.A.
Open Access
Deciphering the intricate role of mTOR signaling and autophagy in Parkinson’s disease and therapeutic prospects
Journal of Applied Pharmaceutical Science
March 2024
Narayanan L.
Open Access
Neuroprotective effects of trehalose following middle cerebral artery occlusion in rats
Interdisciplinary Neurosurgery Advanced Techniques and Case Management
December 2023
Forouzanfar F.
Open Access
Profiling neuroprotective potential of trehalose in animal models of neurodegenerative diseases: A systematic review
Neural Regeneration Research
June 2023
Yap K.H.
Open Access
Role of Nrf2 in aging, Alzheimer's and other neurodegenerative diseases
Ageing Research Reviews
December 2022
George M.
Disaccharide trehalose in experimental therapies for neurodegenerative disorders: Molecular targets and translational potential
Pharmacological Research
September 2022
Pupyshev A.B.
GSK-3β-mediated regulation of Nrf2/HO-1 signaling as a new therapeutic approach in the treatment of movement disorders
Pharmacological Reports
August 2022
Soni D.
A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies
Pharmaceuticals
June 2022
Suzen S.
Open Access
Trehalose and carnosic acid induced LC3I, LC3II ratio, P62 down-regulation and cleaved caspase 3 expression in neural stem cells
Bratislava Medical Journal
2022
Haghdoost-Yazdi H.
Open Access
Effects of trehalose on NFE2L2, catalase, and superoxide dismutase in the kidney of aged rats
Molecular Biology Research Communications
2022
Hozhabri Y.
Therapeutics in the Pipeline Targeting a-Synuclein for Parkinson’s Disease
Pharmacological Reviews
1 January 2022
Jasutkar H.G.
Open Access
Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson’s Disease
Frontiers in Pharmacology
23 November 2021
Wang Y.
Open Access
Nrf2 activation and downstream effects: Focus on parkinson’s disease and brain angiotensin
Antioxidants
November 2021
Parga J.A.
Open Access
Oxidopamine and oxidative stress: Recent advances in experimental physiology and pharmacology
Chemico Biological Interactions
25 February 2021
Pantic I.
Targeting ROS-Dependent AKT/GSK-3β/NF-κB and DJ-1/Nrf2 Pathways by Dapagliflozin Attenuates Neuronal Injury and Motor Dysfunction in Rotenone-Induced Parkinson's Disease Rat Model
ACS Chemical Neuroscience
17 February 2021
Arab H.H.